Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IL-6 contributes to hair loss by shortening the growth phase and causing hair follicles to regress.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Testosterone increases cell growth and reduces IL-6 in gum cells.

The inhibitor DPP can promote hair growth.

The conclusion is that the IL-6/STAT3 activation affects p63 expression in healing wounds, which may help in hair follicle regeneration.

Fruit acids can help prevent skin aging from UV exposure.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Clascoterone may be an effective topical treatment for hair loss.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

FGF21 can help reduce skin inflammation caused by C. acnes.

Particulate matter causes inflammation in hair cells, potentially harming hair growth.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Tsukushi helps control inflammation and aids in wound healing.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Opophytum forskahlii seed oil may help with anti-aging and hair growth.